Gynecological Benignities Causing Obstructive Uropathy. Review of the Literature

Review OA: diamond CC0
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This review discusses obstructive uropathy caused by benign gynecological conditions, highlighting its rarity and the importance of considering uropathy in these patients.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Obstructive uropathy is defined the clinical entity that is characterized by changing the structural and functional feature of the urinary system due to interruption of normal urinary runoff. Gynecological benignities could rarely cause obstructive uropathy. Material and Methods: In this study the incidence and the severity of obstructive uropathy caused by gynecological benignities, was investigated. Additionally, we examined the spectrum of the contigent therapeutical procedures, in order to contend with this severe clinical entity, as well as the dangerous for life complication of urosepsis. Results: Gynecological benignities can cause obstructive uropathy. These conditions are rarely faced, composing a challenging problem for physicians. In the spectrum of these conditions are included adnexal masses, leiomyomas, pelvic inflammatory disease and endometriosis. Conclusions: Obstructive uropathy due to gynecological benignities is a very rare, difficult and challenging condition and physicians should always consider the existence of uropathy in such cases.

My notes (saved in your browser only)

MeSH descriptors

Genital Diseases, Female Ureteral Obstruction Urethral Obstruction Female Female Genital Diseases, Female Genital Diseases, Female Humans Humans Incidence Incidence Treatment Outcome Treatment Outcome Ureteral Obstruction Ureteral Obstruction Urethral Obstruction Urethral Obstruction

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (22)

Source provenance

europepmc
last seen: 2026-10-15T06:08:49.021275+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:29:04.095004+00:00
License: CC0 · commercial use OK